CTOs on the Move

Joint Commission Resources

www.jcrinc.com

 
Joint Commission Resources is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.jcrinc.com
  • 1515 W 22nd St Ste 1300
    Oak Brook, IL USA 60523
  • Phone: 630.268.7400

Executives

Name Title Contact Details

Similar Companies

Villa San Ramon

Villa San Ramon is a San Ramon, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hims & Hers Health,

Hims is a company that provides telemedicine and e-commerce solutions for mens health and wellness.

The Center for Healthcare Information and Analysis

Two things distinguish CHIA in our pursuit of improving the Massachusetts health care system: our public-interest perspective, and our unique data sets. Our perspective is rooted in our independence – our agenda and findings are not colored by the special interests of industry or politics – and in the talents and commitment of CHIA employees. CHIA`s mission is to be the agency of record for Massachusetts health care information, to responsibly steward sensitive and confidential data, and to objectively report reliable and meaningful information about the quality, affordability, utilization, access, and outcomes of the Massachusetts health care system. We pursue this mission in the public interest. This informs our objective perspective, and our commitment to serving a broad, diverse audience. We are a hub, connecting our products to policymakers, public and private payers and providers, employers, researchers, and the residents of Massachusetts. Our vision is a transparent health care system where reliable information provides common ground for improvement and empowers people and organizations to make informed decisions.

Active Nutrition

Active Nutrition is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.